A model for predicting effect of treatment on progression-free survival using MRD as a surrogate end point in CLL
Dimier, N., Delmar, P., Ward, C., Morariu-Zamfir, R., Fingerle-Rowson, G., Bahlo, J., Fischer, K., Eichhorst, B., Goede, V., van Dongen, J. J. M., Ritgen, M., Böttcher, S., Langerak, A. W., Kneba, M., Hallek, M.
American Society of Hematology (ASH)
Published 2018
American Society of Hematology (ASH)
Published 2018
| Publication Date: |
2018-03-06
|
|---|---|
| Publisher: |
American Society of Hematology (ASH)
|
| Print ISSN: |
0006-4971
|
| Electronic ISSN: |
1528-0020
|
| Topics: |
Biology
Medicine
|
| Keywords: |
Lymphoid Neoplasia, Clinical Trials and Observations
|
| Published by: |